clofibrate has been researched along with i(3)so3-galactosylceramide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, T; Hara, A; Kamijo, Y; Kyogashima, M; Nakajima, T; Sheng, X; Sugiyama, E; Takahashi, K; Tanaka, N; Wang, L; Zhang, X | 1 |
1 other study(ies) available for clofibrate and i(3)so3-galactosylceramide
| Article | Year |
|---|---|
Attenuation of kidney injuries maintains serum sulfatide levels dependent on hepatic synthetic ability: a possible involvement of oxidative stress.
Topics: Acute Disease; Animals; Clofibrate; Disease Models, Animal; Drug Antagonism; Female; Gene Expression Regulation, Enzymologic; Hypolipidemic Agents; Kidney; Kidney Diseases; Liver; Mice; Mice, 129 Strain; Oxidative Stress; Serum Albumin, Bovine; Sulfoglycosphingolipids; Sulfotransferases | 2012 |